Literature DB >> 8647970

Treatment of pyoderma gangrenosum.

R K Chow1, V C Ho.   

Abstract

Critical to the proper management of pyoderma gangrenosum are correct diagnosis, identification and treatment of any underlying disorder, and the proper choice of topical and systemic therapy. Many agents are available for the treatment of pyoderma gangrenosum. We review the current therapeutic options, their efficacy and side effects, and we offer some guidelines for their proper selection.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8647970     DOI： 10.1016/s0190-9622(96)90285-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  33 in total

1.  Pyoderma gangrenosum in childhood--the importance of early recognition.

Authors:  Hazel Bell; Richard Parslew
Journal:  Eur J Pediatr       Date:  2002-01       Impact factor: 3.183

Review 2.  Unusual causes of cutaneous ulceration.

Authors:  Jaymie Panuncialman; Vincent Falanga
Journal:  Surg Clin North Am       Date:  2010-12       Impact factor: 2.741

3.  Pyoderma gangrenosum: a rare cause of breast ulceration.

Authors:  Georgina Duke; Ahmad Al Samaraee; Akhtar Husain; Simon Meggitt; Tarannum Fasih
Journal:  Ochsner J       Date:  2012

4.  Violaceous-rimmed ulcers.

Authors:  Cindy Berthelot; Jennifer Clay Cather
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-04

5.  Pyoderma gangrenosum in ulcerative colitis: considerations for an early diagnosis.

Authors:  K I Papageorgiou; R G Mathew; M G Kaniorou-Larai; A Yiakoumetis
Journal:  BMJ       Date:  2005-12-03

6.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

7.  Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study.

Authors:  Adam V Weizman; Brian Huang; Stephan Targan; Marla Dubinsky; Phillip Fleshner; Manreet Kaur; Andrew Ippoliti; Deepa Panikkath; Eric Vasiliauskas; David Shih; Dermot P B McGovern; Gil Y Melmed
Journal:  J Cutan Med Surg       Date:  2014-10       Impact factor: 2.092

8.  Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

Authors:  T N Brooklyn; M G S Dunnill; A Shetty; J J Bowden; J D L Williams; C E M Griffiths; A Forbes; R Greenwood; C S Probert
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

Review 9.  Cutaneous manifestation of gastrointestinal disease.

Authors:  Maral Rahvar; Justin Kerstetter
Journal:  J Gastrointest Oncol       Date:  2016-04

Review 10.  Pyoderma gangrenosum after orthopaedic or traumatologic surgery: a systematic revue of the literature.

Authors:  Stephan Ebrad; Mathieu Severyns; Ahmed Benzakour; Benoit Roze; Christian Derancourt; Guillaume-Anthony Odri; Jean-Louis Rouvillain
Journal:  Int Orthop       Date:  2017-11-08       Impact factor: 3.075
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.